Skip to search formSkip to main contentSkip to account menu

IDEC-152

Known as: anti-CD23 monoclonal antibody, IDEC-152 monoclonal antibody, MOAB IDEC-152 
National Institutes of Health

Related topics

Related topics

1 relation
lumiliximab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Anti-CD20 Antibody Rituximab and Anti-CD23 Antibody IDEC-152 Induce Apoptosis of Malignant B-Cells in Combination with Chemical Antagonists of XIAP.
We tested the effects of Rituximab (anti-CD20) and IDEC-152 (anti-CD23) on apoptosis of B-cell malignancies, using established… 
Review
2003
Review
2003
Commentary (O'Brien): Current Status of Monoclonal Antibody Therapy for Chronic Lymphocytic Leukemia
Dr. Nabhan and his coauthors have written a comprehensive review of the use of monoclonal antibodies in the treatment of chronic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)